Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richardson, F. C.
Right arrow Articles by Bendele, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richardson, F. C.
Right arrow Articles by Bendele, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 27, No. 6, 607-617 (1999)
DOI: 10.1177/019262339902700601

An Evaluation of the Toxicities of 2' -Fluorouridine and 2'-Fluorocytidine-HCI in F344 Rats and Woodchucks (Marmota monax)

Frank C. Richardson

NeXstar Pharmaceuticals, Inc., Boulder, Colorado 80301

Bud C. Tennant

Marmotech, Inc., Ithaca, New York 14850

Denny J. Meyer

NeXstar Pharmaceuticals, Inc., Boulder, Colorado 80301

Katherine A. Richardson

Molecular Biology Experimental Design, Louisville, Colorado 80027

Peter C. Mann

Experimental Pathology Laboratories, Research Triangle Park, North Carolina 27709

Gregory R. Mcginty

NeXstar Pharmaceuticals, Inc., Boulder, Colorado 80301

Julie L. Wolf

NeXstar Pharmaceuticals, Inc., Boulder, Colorado 80301

Philip M. Zack

NeXstar Pharmaceuticals, Inc., Boulder, Colorado 80301

Raymond A. Bendele

NeXstar Pharmaceuticals, Inc., Boulder, Colorado 80301

The toxicities of 2'-fluorouridine (2'-FU) and 2'-fluorocytidine-HCl (2'-FC) were separately evaluated in 2 species, male Fischer 344 (F334) rats and woodchucks. Particular attention was focused on the ability of these nucleosides to induce toxicities similar to those induced by the antiviral drug fialuridine (FIAU). 2'-FU or 2'-FC was administered to F344 male rats by intravenous injection at doses of 5, 50, and 500 mg/kg/day for 90 consecutive days and to male and female woodchucks at doses of 0.75 and 7.5 mg/kg/ day for 90 consecutive days. Clinical chemistry, hematology, and urinalysis (woodchuck only) profiles were assessed during and at the termination of the study. At necropsy, organs were weighed and tissues collected for routine histologic analysis. Cytochrome c oxidase activity, citrate synthase activity, and mitochondrial DNA content were measured, and micronucleus formation in the bone marrow (rats only) was evaluated. No adverse clinical effects were observed in either species. Rats treated with high doses of either 2'-FU or 2'-FC had body weights that were 90% of those of controls. 2'-FU and 2'-FC both induced a moderate decrease in the median lymphocyte count, and 2'-FC and 2'-FU induced a mild increase in mean corpuscular hemoglobin and mean corpuscular volume. Both compounds caused slight to moderate, reversible, histologic changes in the spleen and thymus. In the woodchuck, 2'-FC caused a slight increase in mean absolute lymphocytes, and 2'-FC and 2'-FU slightly increased hepatic periportal vacuolation and/ or mononuclear cell infiltration. In summary, neither compound showed evidence of the toxicity induced by fialuridine in either species. Although compound effects were observed, none of these effects were considered to be adverse, and the no-observed adverse effect level was determined to be 500 mg/kg/day for both compounds in the male F344 rat and 7.5 mg/kg/day in the woodchuck.

Key Words: Nucleoside analogs • aptamer • mtDNA • cytochrome c oxidase • intravenous


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. J. Bajramovic, R. Volmer, S. Syan, S. Pochet, and D. Gonzalez-Dunia
2'-Fluoro-2'-Deoxycytidine Inhibits Borna Disease Virus Replication and Spread
Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1422 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. J. Stuyver, T. R. McBrayer, T. Whitaker, P. M. Tharnish, M. Ramesh, S. Lostia, L. Cartee, J. Shi, A. Hobbs, R. F. Schinazi, et al.
Inhibition of the Subgenomic Hepatitis C Virus Replicon in Huh-7 Cells by 2'-Deoxy-2'-Fluorocytidine
Antimicrob. Agents Chemother., February 1, 2004; 48(2): 651 - 654.
[Abstract] [Full Text] [PDF]